Enhanced B cell cytotoxicity of CDIM binding antibody

Details for Australian Patent Application No. 2004288231 (hide)

Owner Palingen, Inc.

Inventors Neelima, M. Bhat; Nelson, N. H. Teng; Marcia, M. Bieber; Martin, E. Sanders

Agent Spruson & Ferguson

Pub. Number AU-A-2004288231

PCT Pub. Number WO2005/044998

Priority 60/517,775 05.11.03 US

Filing date 5 November 2004

Wipo publication date 19 May 2005

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/044998 Priority application(s): WO2005/044998

3 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004288233-Process for electrolytic production of aluminum

2004288228-Use of particulate labels in bioanalyte detection methods